COMP <GO>
CL vs KVUE // REVENUE GROWTH (YOY)
Colgate-Palmolive Company (NYSE) VS. Kenvue Inc. (NYSE) • 15-METRIC TALLY: CL 8
— KVUE 6
▲ REVENUE GROWTH (YOY) LEADER: CL
LAST: $93.16 (+1.60%) • MKT CAP: $74.26B
revenue-growth
1.40%
LAST: $19.56 (+1.19%) • MKT CAP: $37.57B
revenue-growth
-2.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CL VS. KVUE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CL | KVUE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.10% | 58.10% | +2.00 | CL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 44.00% | 11.50% | +32.50 | CL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 15.4x | +4.10 | KVUE | /valuation <GO> |
| Free Cash Flow Yield | 4.42% | 4.58% | -0.16 | KVUE | /fcf-yield <GO> |
| Operating Margin | 16.20% | 16.00% | +0.20 | CL | /operating-margins <GO> |
| Net Profit Margin | 10.50% | 9.70% | +0.80 | CL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 1.40% | -2.10% | +3.50 | CL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.21% | -4.21 | KVUE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.90 | 2.21 | +4.69 | CL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | KVUE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 63.2 | -8.50 | KVUE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.05 | +0.06 | CL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.4x | 23.8x | +8.60 | KVUE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $74.26B | $37.57B | $36.69B | CL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CL REV | KVUE REV | CL GROSS % | KVUE GROSS % | CL FCF | KVUE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.38B | $15.12B | 60.1% | 58.1% | $3.28B | $1.72B |
| FY 2024 | $20.10B | $15.46B | 60.5% | 58.0% | $3.20B | $1.33B |
| FY 2023 | $19.46B | $15.44B | — | — | $2.87B | $2.47B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CL // BETA 1.11
KVUE // BETA 1.05